EIF5A2 and colorectal carcinoma: In CRC, HERC3 used to be illustrated to have none mutations in CRC and also was once reported to inhibit the metastasis of CRC by targeting EIF5A2 and further controlled the epithelial-mesenchymal transition 7; 16.